Abstract:Immunotherapy can improve the survival of patients with advanced lung squamous cell carcinoma (LUSC). T cytotoxic cells are one of the main members of the immune microenvironment. Herein, we aimed to identify the roles of T-cell cytotoxic markers interleukin 18 (IL18) receptor 1 (IL18R1) in the LUSC progression using bioinformatics, clinical tissue specimen, and cell experiment. We assessed the association between the IL18R1 expression and immune infiltration and IL18R1-related competing RNA network. The IL18R1 expression was downregulated in the LUSC tissues. The IL18R1 expression downregulation was associated with diagnosis and short overall survival and disease-specific survival, and it was also an independent risk factor for dismal survival time in LUSC. IL18R1-related nomograms predicted the survival time of patients with LUSC. IL18R1 overexpression inhibited the proliferation, migration, and invasion of LUSC cells. The IL18R1 expression was significantly associated with the microenvironment (stromal, immune, and estimate scores), immune cells (such as the T cells, cytotoxic cells, CD8 T cells), and immune cell markers (such as the CD8A, PD-1, and CTLA4) in LUSC. AC091563.1 and RBPMS-AS1 downregulation was positively associated with the IL18R1 expression, negatively associated with the miR-128-3p expression, and associated with short disease-specific survival and progression in LUSC. In conclusion, IL18R1 was significantly downregulated and associated with the prognosis and immune microenvironment. IL18R1 overexpression inhibits the growth and migration of cancer cells in LUSC. Furthermore, AC091563.1 and RBPMS-AS1 might compete with IL18R1 to bind miR-128-3p for participating in LUSC progression. These results showed that IL18R1 is a biomarker for evaluating the prognosis of patients with LUSC.

Overexpression of Interleukin-18 Protein Reduces Viability and Induces Apoptosis of Tongue Squamous Cell Carcinoma Cells by Activation of Glycogen Synthase Kinase-3Β Signaling.

Interleukin-18 expression in oral squamous cell carcinoma: its role in tumor cell migration and invasion, and growth of tumor cell xenografts.

Extracellular interleukin-17F has a protective effect in oral tongue squamous cell carcinoma

[Effects of Epidermal Growth Factor Receptor Gene Silencing Mediated by Short Hairpin RNA on Proliferation and Apoptosis of Human Tongue Carcinoma Cells].

Isoliquiritigenin Inhibits Proliferation and Induces Apoptosis in Tongue Squamous Cell Carcinoma by Modulating miR-21/FOXG1 Pathway

Overexpression of Transforming Growth Factor Type III Receptor Restores TGF-β1 Sensitivity in Human Tongue Squamous Cell Carcinoma Cells

Study on the Effects of Overexpression of Exogenous Notch1 in Tongue Squamous Cell Carcinoma Cells on Cell Growth and Expression of Epidermal Growth Factor Receptor in Vitro

Effects of Interleukin-6 on STAT3-regulated signaling in oral cancer and as a prognosticator of patient survival

Effects of Inducing Apoptosis and Inhibiting Proliferation of Sirna on Polyadenylate-Binding Protein-Interacting Protein 1 in Tongue Cell Carcinoma.

Adenovirus-mediated overexpression of interleukin-21 regulates the development of oral squamous cell carcinoma in vitro

Interleukin-17A promotes tongue squamous cell carcinoma metastasis through activating miR-23b/versican pathway

Regulation of Microrna-21 ASO on Proliferation and Apoptosis of TSCC Cell Lines

Downregulation of T-cell cytotoxic marker IL18R1 promotes cancer proliferation and migration and is associated with dismal prognosis and immunity in lung squamous cell carcinoma

Functional toll-like receptor 3 expressed by oral squamous cell carcinoma induced cell apoptosis and decreased migration.

Expressions and significance of autophagy related gene Beclin-1 and apoptosis related gene Bcl-2 in tongue squamous cell carcinoma

Overexpression of Lncrna H19 Leads to Reduced Proliferation in TSCC Cells Through Mir-675-5p/gpr55.

Bcl-xL Overexpression and Its Association with the Progress of Tongue Carcinoma.

Targeted Blockage of STAT3 Signaling Pathway with JSI-124 Suppresses the Proliferation of Tongue Squamous Cell Carcinoma Tca- 8113 Cells

Suppression of tongue squamous cell carcinoma growth by inhibition of Jagged1 in vitro and in vivo.

Down-regulation of SOX18 inhibits laryngeal carcinoma cell proliferation, migration, and invasion through JAK2/STAT3 signaling.

miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells.